Transdigm Group INC quarterly report, Q1 FY2022

TransDigm Group Incorporated — Fiscal Q1 2022 Form 10-Q

Reporting period: Thirteen weeks ended January 1, 2022, compared with January 2, 2021. The interim financial statements are unaudited. TransDigm designs, produces and supplies highly engineered aerospace components, with reporting segments in Power & Control, Airframe and Non-aviation.

Key Financial Metrics

MetricQ1 FY2022Q1 FY2021Change
Net sales$1,194 million$1,108 millionUp 7.8%
Gross profit$661 million$541 millionUp 22.2%
Gross margin55.4%48.8%Up 6.6 percentage points
Income from operations$455 million$315 millionUp 44.4%
Operating margin38.1%28.4%Up 9.7 percentage points
Income from continuing operations$163 million$50 millionUp $113 million
Net income attributable to TD Group$163 million$50 millionUp $113 million
Net income applicable to common stockholders$117 million$(23) millionImproved by $140 million
Basic and diluted EPS$1.98$(0.42)Improved by $2.40
EBITDA As Defined$565 million$474 millionUp 19.2%
EBITDA As Defined margin47.3%42.8%Up 4.5 percentage points
Operating cash flow$279 million$274 millionUp $5 million
Capital expenditures$25 million$31 millionDown $6 million

Liquidity, Debt and Balance Sheet

  • Cash and cash equivalents were $4.813 billion at January 1, 2022, compared with $4.787 billion at September 30, 2021.
  • Total debt, including the trade receivable securitization facility and net of issuance costs and discounts, was $19.814 billion, compared with $19.998 billion at September 30, 2021.
  • Cash liquidity, defined as cash plus revolving-credit availability, was approximately $5.590 billion, including $777 million available under the revolving facility.
  • The revolving-credit facility capacity increased from $760 million to $810 million in December 2021. The Company repaid a prior $200 million revolving-facility draw.
  • No tranche of term loans or notes matures before August 2024. The Company reported compliance with its debt covenants.
  • Net cash used in financing activities was $225 million, primarily reflecting the $200 million revolver repayment, $46 million of dividend-equivalent payments and $19 million of term-loan repayments.

Material Changes Versus Prior Comparable Period

  • Organic sales increased $96 million, or 8.7%, driven primarily by commercial aftermarket sales, which increased $112 million, or 49.7%, and commercial OEM sales, which increased $28 million, or 12.5%.
  • Defense OEM and aftermarket sales decreased $46 million, or 8.6%, primarily because of supply-chain-related fulfillment delays.
  • Power & Control sales increased 8.2% to $650 million; Airframe sales increased 9.1% to $506 million; Non-aviation sales decreased 11.6% to $38 million.
  • Cost of sales declined 6.0% despite higher sales, reflecting favorable commercial-aftermarket mix, operating leverage, lower COVID-19 restructuring costs and lower foreign-currency losses.
  • Selling and administrative expenses decreased 13.7% to $170 million, partly due to reduced COVID-19 restructuring costs, lower stock compensation expense and lower bad-debt expense.
  • COVID-19 restructuring costs were not material in Q1 FY2022 versus $21 million in Q1 FY2021.
  • Interest expense declined modestly to $264 million from $267 million. The weighted-average cash interest rate on borrowings was 5.1%.
  • The effective tax rate increased to 15.7% from 5.5%, although it remained below the 21% federal statutory rate primarily because of excess tax benefits from share-based compensation.

Guidance, Outlook, Risks and Unusual Items

  • Management expects COVID-19 to continue adversely affecting fiscal 2022 sales, net income and EBITDA As Defined relative to pre-pandemic levels. The pace of commercial aerospace recovery remains uncertain, particularly for international travel.
  • Management reported improving commercial air travel, narrow-body utilization, air cargo demand and narrow-body aircraft deliveries, but noted continued weakness in international travel and wide-body production.
  • Global supply-chain disruption, particularly for electronic parts, may constrain production. Aerospace certification requirements may make supplier or component substitutions lengthy and costly.
  • The Company expects its value-driven operating strategies and operating leverage to support strong margins and sufficient cash flow for interest obligations and liquidity needs. No formal full-year numerical guidance is provided in the filing text.
  • The Department of Defense Office of Inspector General completed an audit and recommended that TransDigm voluntarily refund at least $20.8 million related to 150 contracts. TransDigm disputes the report’s analysis and recorded no loss contingency because payment was considered uncertain.
  • TransDigm received approximately $1 million from a final working-capital settlement related to the prior Souriau-Sunbank divestiture, recorded in discontinued operations.
  • The Cobham Aero Connectivity acquisition was completed in fiscal 2021 for $945 million; final purchase-price allocation adjustments were recorded during the quarter. No acquisitions or divestitures occurred in Q1 FY2022.
  • On January 27, 2022, after quarter-end, the Board authorized a new $2.2 billion stock-repurchase program, replacing the prior $650 million authorization. No repurchases occurred during the quarter.
  • Principal ongoing risks include high leverage and refinancing risk, commercial aerospace cyclicality and flight-hour sensitivity, COVID-19 impacts, supply-chain constraints, defense-contract audits, customer concentration, acquisition integration, foreign-currency exposure, litigation and regulatory or environmental liabilities.

Investor Verification Items

  • Verify the sustainability of the commercial aftermarket recovery and whether international flight hours and wide-body production improve.
  • Monitor defense-sales recovery and resolution of supply-chain delays, especially for electronic components.
  • Assess debt maturities beginning in 2024, interest-rate exposure, refinancing needs and covenant headroom.
  • Track the outcome of the DoD OIG voluntary-refund recommendation and any related contingency recognition.
  • Reconcile EBITDA As Defined to GAAP earnings and operating cash flow, noting that it excludes significant interest, taxes, stock compensation and other items.
  • Evaluate the timing and scale of any share repurchases under the new $2.2 billion authorization relative to leverage and liquidity priorities.